Coenzyme Q10 and Cardiovascular Health
Coenzyme Q10 is a proven adjuvant treatment of cardiovascular diseases, i.e., heart failure, atrial fibrillation, and myocardial infarction. Clinical studies have also shown beneficial outcomes in risk factors, e.g., dyslipidemias, glucose control, and hypertension. Coenzyme Q10 improves symptoms and survival in heart failure patients and improves heart function and survival in elderly community living individuals.
Newest Articles About CoQ10 and Cardiovascular Health
Coenzyme Q10 Supplementation Clinical Evidence
Clinical evidence shows: daily CoQ10 supplementation reduces mortality risk and hospitalization risk in chronic heart failure patients, enhances antioxidant activity and anti-inflammation activity, promotes better endothelial function and modestly reduces systolic blood pressure.
Coenzyme Q10 and Heart Failure Meta-Analysis
In heart failure patients, Coenzyme Q10 supplementation reduces all-cause mortality risk, hospitalization for heart failure, and biomarker levels for heart failure. CoQ10 improves left ventricular ejection fraction and 6-minute walk test results. With no major adverse effects.
Coenzyme Q10 and Cardiovascular Diseases
What is the rationale for the use of Coenzyme Q10 (CoQ10) in the treatment of cardiovascular diseases? Worldwide, cardiovascular diseases are the number one cause of death. Mitochondrial dysfunction, oxidative stress, and inflammation are key [...]
